Centene is trading 4.3% lower at $72.75, with no new company-specific catalyst surfaced; the decline appears more consistent with sector and market pressure. - On November 5, equities are sharply lower as technology-led losses and policy uncertainty weigh on markets; healthcare is also under pressure. - Centene gained 12.64% on November 4 as Medicaid-focused insurers rallied on expectations of more favorable post-election policy. Reuters linked the rally to potential delays to Medicaid cuts and improved ACA-subsidy prospects.